Literature DB >> 19802752

Psychometric properties and the predictive validity of the insomnia daytime worry scale: a pilot study.

Håvard Kallestad1, Bjarne Hansen, Knut Langsrud, Odin Hjemdal, Tore C Stiles.   

Abstract

The relationship between presleep worry and insomnia has been investigated in previous studies, but less attention has been given to the role of daytime worry and symptoms of insomnia. The aims of the current study were (a) to assess the psychometric properties of a novel scale measuring insomnia-specific worry during daytime and (b) to examine whether levels of daytime worry predict severity of insomnia symptoms. Participants (N = 353) completed the Insomnia Daytime Worry Scale (IDWS) and the Insomnia Severity Index. An explorative principal-axis factor analysis extracted two factors from the IDWS, accounting for 70.5% of the variance. The IDWS demonstrated good reliability. The total score of IDWS and both factors predicted levels of insomnia severity in two separate hierarchical regression analyses. This preliminary evidence suggests that the IDWS is a valid and reliable scale to measure daytime worry in insomnia.

Entities:  

Mesh:

Year:  2010        PMID: 19802752     DOI: 10.1080/16506070903115317

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  3 in total

1.  Psychometric properties of the Turkish version of the Anxiety and Preoccupation about Sleep Questionnaire in clinical and non-clinical samples.

Authors:  Ömer Faruk Uygur; Fatma Özlem Orhan; Hilal Uygur; Ali Kandeger; Onur Hursitoglu
Journal:  Sleep Sci       Date:  2022 Jan-Mar

2.  A Systematic Review of Instruments for the Assessment of Insomnia in Adults.

Authors:  Raja Mahamade Ali; Monica Zolezzi; Ahmed Awaisu
Journal:  Nat Sci Sleep       Date:  2020-07-02

3.  Cognitive behavioral therapy for insomnia in euthymic bipolar disorder: study protocol for a randomized controlled trial.

Authors:  Mette Kvisten Steinan; Karoline Krane-Gartiser; Knut Langsrud; Trond Sand; Håvard Kallestad; Gunnar Morken
Journal:  Trials       Date:  2014-01-16       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.